Learn about PERJETA® (pertuzumab), a treatment for 2 types of HER2-postitive breast cancer.
What does PERJETA treat? PERJETA® (pertuzumab) is approved for use in combination with Herceptin® (trastuzumab) and docetaxel in people who have HER2-positive